T1	SNP 0 7	+331G/A
T2	Entity 23 49	progesterone receptor gene
R1	SNP_coupled_gene Arg1:T1 Arg2:T2	
T3	Entity 4 7	G/A
T4	Entity 0 4	+331
R2	SNP_location Arg1:T1 Arg2:T4	
R3	Nucleotide_substitution Arg1:T1 Arg2:T3	
T5	Cancer 90 103	breast cancer
T6	Association 82 86	risk
E1	Association:T6 bc:T5 snp_int:T1
T7	Entity 51 77	postmenopausal hormone use
R4	Risk_Factor Arg1:T1 Arg2:T7	
T8	Entity 108 127	functional promoter
R5	SNP_location Arg1:T1 Arg2:T8	
T9	Association 229 233	risk
E2	Association:T9 snp_int:T13 bc:T12
T10	Effect_Type 219 228	increased
R6	Effect_type_marker Arg1:E2 Arg2:T10	
A1	Effect_Type E2 Increase
T11	Entity 237 251	postmenopausal
T12	Cancer 252 265	breast cancer
T13	SNP 128 140	polymorphism
R7	SNP_location Arg1:T13 Arg2:T8	
T14	Entity 148 169	progesterone receptor
T15	Entity 171 173	PR
R8	Equiv Arg1:T15 Arg2:T14	
R9	SNP_coupled_gene Arg1:T13 Arg2:T14	
R10	Risk_Factor Arg1:T13 Arg2:T11	
T16	SNP 300 317	genetic variation
T17	Entity 321 323	PR
R11	SNP_coupled_gene Arg1:T16 Arg2:T17	
T18	Association 328 332	risk
E3	Association:T18 snp_int:T16 bc:T20
T19	Spec 267 274	Whether
R12	Speculation_marker Arg1:E3 Arg2:T19	
T20	Cancer 336 349	breast cancer
T21	Entity 365 387	postmenopausal hormone
T22	Entity 389 392	PMH
R13	Equiv Arg1:T22 Arg2:T21	
R14	Risk_Factor Arg1:T16 Arg2:T22	
T23	Spec 504 512	evaluate
T24	Cancer 528 541	breast cancer
T25	Association 542 552	associated
E4	Association:T25 bc:T24 snp_int:T27
R15	Speculation_marker Arg1:E4 Arg2:T23	
T26	Entity 604 611	PMH use
T27	SNP 569 575	+331 A
R16	Risk_Factor Arg1:T27 Arg2:T26	
T28	Entity 574 587	A risk allele
R17	SNP_allele Arg1:T27 Arg2:T28	
R18	SNP_coupled_gene Arg1:T27 Arg2:T17	
T29	Entity 569 573	+331
R19	SNP_location Arg1:T27 Arg2:T29	
T30	Level 1486 1492	2-fold
T31	Effect_Type 1493 1502	increased
T32	Association 1503 1507	risk
E5	Association:T32 bc:T35 snp_int:T38
A2	Effect_Type E5 Increase
A3	Level E5 High
R20	Effect_type_marker Arg1:E5 Arg2:T31	
R21	Level_marker Arg1:E5 Arg2:T30	
T33	Spec 1471 1479	evidence
R22	Speculation_marker Arg1:E5 Arg2:T33	
T34	Entity 1522 1536	postmenopausal
T35	Cancer 1537 1550	breast cancer
T36	Neg 1557 1562	never
T37	Entity 1572 1575	PMH
R23	Negation_marker Arg1:T37 Arg2:T36	
T38	SNP 1585 1592	+331G/A
T39	Entity 1585 1589	+331
R24	SNP_location Arg1:T38 Arg2:T39	
R25	SNP_coupled_gene Arg1:T38 Arg2:T17	
T40	SNP 1263 1270	+331G/A
T41	Entity 1263 1267	+331
R26	SNP_location Arg1:T40 Arg2:T41	
T42	Neg 1288 1291	not
T43	Association 1292 1302	associated
E6	Association:T43 snp_int:T40 bc:T44
R27	Negation_marker Arg1:E6 Arg2:T42	
T44	Cancer 1308 1321	breast cancer
T45	Entity 1333 1337;1409 1418	past PMH users
R28	Risk_Factor Arg1:T40 Arg2:T45	
T46	Entity 1371 1378;1409 1418	current PMH users
R29	Risk_Factor Arg1:T40 Arg2:T46	
T47	Entity 960 963	PMH
T48	SNP 1019 1026	+331G/A
R30	Risk_Factor Arg1:T48 Arg2:T47	
R31	SNP_coupled_gene Arg1:T48 Arg2:T17	
R32	SNP_coupled_gene Arg1:T40 Arg2:T17	
T49	Entity 832 837	Women
R33	Population_assignment Arg1:T1 Arg2:T49	
R34	Population_assignment Arg1:T27 Arg2:T49	
R35	Population_assignment Arg1:T16 Arg2:T49	
R36	Population_assignment Arg1:T13 Arg2:T49	
R38	Population_assignment Arg1:T40 Arg2:T50	
T50	Entity 1098 1103	women
T51	Level 893 896	31%
T52	Effect_Type 897 906	increased
T53	Association 907 911	risk
E7	Association:T53 bc:T54 snp_int:T58 snp_int2:T55
T54	Cancer 926 939	breast cancer
A4	Effect_Type E7 Increase
R39	Effect_type_marker Arg1:E7 Arg2:T52	
R40	Level_marker Arg1:E7 Arg2:T51	
T55	SNP 869 876	variant
R41	Equiv Arg1:T55 Arg2:T27	
T56	Entity 859 860;877 878	1 A
T57	Entity 864 868;877 886	both A alleles
R43	Genotype Arg1:T55 Arg2:T57	
R44	Population_assignment Arg1:T55 Arg2:T49	
T58	SNP 869 876	variant
R45	Population_assignment Arg1:T58 Arg2:T49	
R42	Genotype Arg1:T58 Arg2:T56	
T59	Association 995 1006	association
E8	Association:T59 bc:T54 snp_int:T48
T60	Effect_Type 1064 1069	<0.05
R37	Effect_type_marker Arg1:E8 Arg2:T60	
R46	Population_assignment Arg1:T48 Arg2:T50	
T61	Entity 1023 1026	G/A
R47	Nucleotide_substitution Arg1:T48 Arg2:T61	
T62	Neg 1078 1083	never
T63	Entity 1084 1089;1093 1096	users PMH
R48	Negation_marker Arg1:T63 Arg2:T62	
T64	SNP 1113 1120	variant
T65	SNP 1019 1026	+331G/A
R49	Equiv Arg1:T65 Arg2:T64	
T67	Entity 1019 1023	+331
R50	Nucleotide_substitution Arg1:T65 Arg2:T61	
R51	SNP_location Arg1:T65 Arg2:T67	
R52	SNP_location Arg1:T48 Arg2:T67	
R53	SNP_coupled_gene Arg1:T65 Arg2:T17	
T66	Level 1136 1149	significantly
T68	Effect_Type 1150 1159	increased
T69	Association 1160 1164	risk
E9	Association:T69 snp_int:T64 bc:T70
A5	Effect_Type E9 Increase
A6	Level E9 High
R54	Effect_type_marker Arg1:E9 Arg2:T68	
R55	Level_marker Arg1:E9 Arg2:T66	
R56	Risk_Factor Arg1:T64 Arg2:T63	
T70	Cancer 1168 1181	breast cancer
